Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia
Clinical trial NCT00080496 · COMPLETED
Trial details
- NCT number
- NCT00080496
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Enrollment
- 430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.